Abstract

Objective: To investigate the clinical features, treatment methods, and outcomes of fulminant myocarditis (FM) in children.Methods: The clinical data of 23 children with FM hospitalized in the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (Anhui Provincial Hospital) and Anhui Provincial Children's Hospital from January 2011 to September 2019 were retrospectively analyzed.Results: Among the 23 patients analyzed, 10 were male and 13 were female. The patients aged from 6 months to 14 years old (6.5 ± 3.4 years), and 18 patients were over 3 years old. There were 14 cases with respiratory symptoms, 16 cases with gastrointestinal symptoms, 15 cases with neurological symptoms, and 19 cases with hypoperfusion manifestations. Creatine kinase MB (CK-MB) and cardiac troponin I (CTnI) levels were increased in 19 and 21 cases, respectively. Electrocardiography (ECG) showed ST-T changes in 18 cases and atrioventricular blocks (AVB) in 15 cases. Echocardiography (ECHO) showed cardiac chamber enlargement (CCE) in eight cases, left ventricular systolic dysfunction in five cases, decrease in left ventricular ejection fraction (LVEF) in four cases, reduction in wall motion in two cases, and pericardial effusion in seven cases. Intravenous immunoglobulin (IVIG) and glucocorticoids were administered to 19 and 20 patients, respectively. Fourteen patients were treated with temporary pacemakers, one patient received extracorporeal membrane oxygenation (ECMO), one patient received continuous renal replacement therapy (CRRT), and one patient received ECMO combined with CRRT. Twenty patients improved at discharge, and three patients died.Conclusion: Preschool and school-age children showing hypoperfusion symptoms, such as paleness, cold, clammy limbs, and capillary refill time (CRT) extension, accompanied by vomiting, abdominal pain, dizziness, convulsions, and other symptoms, should be carefully examined for FM. CK-MB, CTnI, ECG, and echocardiogram need to be performed at the earliest opportunity. In the early stages of FM, vital signs should be actively monitored, high-dose IVIG and glucocorticoids should be administered, and life support technologies such as temporary pacemakers, ECMO, and CRRT should be used to increase the survival rate of children with FM as needed.

Highlights

  • Fulminant myocarditis (FM) is an inflammatory process of the myocardium that is an important cause of cardiac dysfunction in children and is characterized by abrupt onset, fast progress, and high mortality [1, 2]

  • IVIG, glucocorticoids, temporary pacemakers, ECMO, and CRRT were administered according to the condition of the patients

  • 78% of children with FM were over 3 years old, showing that the majority were preschool and school-age children

Read more

Summary

Introduction

Fulminant myocarditis (FM) is an inflammatory process of the myocardium that is an important cause of cardiac dysfunction in children and is characterized by abrupt onset, fast progress, and high mortality [1, 2]. Patients may present with acute heart failure, cardiogenic shock, Adams-Stokes syndrome, or fatal arrhythmia in a short time and are usually admitted to the hospital with digestive system symptoms such as vomiting and abdominal pain or neurological symptoms such as dizziness and convulsions [3]. The initial clinical symptoms are often atypical and can be misdiagnosed. The aim of this study was to improve our understanding of the diagnosis and treatment of FM by analyzing the clinical features, treatment methods, and outcomes in children with FM

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call